Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.25 USD
Change Today 0.00 / 0.00%
Volume 0.0
EQUR On Other Exchanges
As of 8:10 PM 06/26/15 All times are local (Market data is delayed by at least 15 minutes).

e- qure corp (EQUR) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/22/14 - $4.50
52 Week Low
06/24/15 - $0.11
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for E- QURE CORP (EQUR)

Related News

No related news articles were found.

e- qure corp (EQUR) Related Businessweek News

No Related Businessweek News Found

e- qure corp (EQUR) Details

E-Qure Corp., a development stage company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices in the United States. Its BST device uses patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was formerly known as ADB International Group, Inc. and changed its name to E-Qure Corp. in August 2014. E-Qure Corp. was incorporated in 1988 and is based in New York, New York.

1 Employees
Last Reported Date: 05/21/15
Founded in 1988

e- qure corp (EQUR) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Chief Technology Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

e- qure corp (EQUR) Key Developments

E-Qure Corp. Signs First Distribution Agreement with Rubifarm S.A

E-Qure Corp. announced that the Company has signed its first distribution agreement with Rubifarm S.A. The agreement goes into effect immediately. After conducting preliminary market research, testing the device, and securing regulatory approval, E-QURE and Rubifarm entered into agreement where Rubifarm S.A. would undertake a minimum electrodes purchasing obligation of $50,000 for the first year, growing up to a minimum of $1,000,000 after 5 years. Local regulatory process has put the agreement into effect. In addition to purchase obligations, the distribution agreement defines the commercial terms of the relationship. In principle, devices will be rented to hospitals and clinics at a small monthly monetary rate to cover service and repairs, while the distributor will sell disposable electrodes on 'treatment days' basis.

E-Qure Corp. announced delayed annual 10-K filing

On 03/31/2015, E-Qure Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

E-Qure Corp. announced delayed 10-Q filing

On 11/14/2014, E-Qure Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EQUR:US $0.25 USD 0.00

EQUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EQUR.
View Industry Companies

Industry Analysis


Industry Average

Valuation EQUR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact E- QURE CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at